Tower Research Capital LLC (TRC) - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,318
-72.7%
4,078
-28.2%
0.00%
-100.0%
Q2 2023$37,823
+130324.1%
5,679
+271.4%
0.00%0.0%
Q1 2023$29
+163.6%
1,529
+205.2%
0.00%
Q4 2022$11
-99.9%
501
-59.9%
0.00%
Q3 2022$15,000
-57.1%
1,250
-52.4%
0.00%
-100.0%
Q2 2022$35,000
-49.3%
2,628
-20.8%
0.00%0.0%
Q1 2022$69,000
-27.4%
3,317
-29.3%
0.00%
-50.0%
Q4 2021$95,000
-33.6%
4,690
+0.1%
0.00%
-50.0%
Q3 2021$143,000
+521.7%
4,686
+475.0%
0.00%
+300.0%
Q2 2021$23,000
-68.9%
815
-52.5%
0.00%0.0%
Q1 2021$74,000
+1750.0%
1,716
+1850.0%
0.00%
Q4 2020$4,000
-94.8%
88
-95.0%
0.00%
-100.0%
Q3 2020$77,000
-75.6%
1,770
-70.3%
0.00%
-92.3%
Q2 2020$316,000
+10433.3%
5,963
+4910.9%
0.01%
Q1 2020$3,000
-66.7%
119
-90.8%
0.00%
-100.0%
Q3 2019$9,000
+125.0%
1,291
+243.4%
0.00%
Q2 2019$4,0000.0%376
-66.5%
0.00%
Q4 2018$4,000
+100.0%
1,122
+247.4%
0.00%
Q3 2018$2,000
+100.0%
323
+223.0%
0.00%
Q1 2018$1,0001000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders